Helping you stay current in drug monitoring




Benzodiazepines: Primary Care’s New Drug Problem

Dr. Jeff Gudin reflects on the impact of Benzodiazepines:

Heightened awareness of the dangers of prescription opioids has prompted a movement to limit use of opioid therapies for patients with acute or chronic pain. Primary care practitioners stand on the front lines of this care shift, and many are curtailing…

Apr 30, 2019

Don’t Withhold Medication-assisted Therapy from Benzodiazepine Users, FDA says

The US Food and Drug Administration has updated its recommendationson co-prescribing benzodiazepines with medication-assisted therapy treatment, stating that buprenorphine and methadone “should not be withheld from patients taking benzodiazepines or other drugs that depress the central nervous system.” While the combination of benzodiazepines or other CNS depressants with…

Apr 03, 2019